GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

(MedPage Today) — Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.
Cognitive performance at 4.1 years of follow-up was similar in participants…

Source link : https://www.medpagetoday.com/neurology/dementia/115661

Author :

Publish date : 2025-05-19 21:31:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

Best Intensive Care Unit Sedative? Head-to-Head Trial Weighs In

Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

Related Posts

Depression Linked to 14% Increased Risk for Heart Failure

‘We can’t stay silent over endometriosis struggle’

Flooding Triggers Major Melioidosis Outbreak in Australia

My AI therapist got me through dark times

AI doesn’t know ‘no’ – and that’s a huge problem for medical bots

Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

Depression Linked to 14% Increased Risk for Heart Failure

‘We can’t stay silent over endometriosis struggle’

Flooding Triggers Major Melioidosis Outbreak in Australia

My AI therapist got me through dark times

AI doesn’t know ‘no’ – and that’s a huge problem for medical bots

Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

Best Intensive Care Unit Sedative? Head-to-Head Trial Weighs In

Categories

Archives